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Background: Nuclear cardiology (NC) procedures are widely used to effectively diagnose coronary disease, stratify risk, and guide patient 
management. However, significant concerns have been raised regarding high radiation doses received by many NC patients, and variation in these 
doses. Professional society guidelines have recommended effective dose of ≤9mSv in at least 50% of studies, however the actual doses used in 
unselected patients in practice have not been previously described.
Methods: : INCAPS collected data on protocols used for all NC myocardial imaging procedures performed in 308 laboratories in 66 countries 
worldwide for a single week selected by each laboratory in March or April 2013. Effective dose was estimated with dose coefficients from ICRP 
Publication 120.
results: 7961 studies were performed during the selected week. Effective doses ranged from 0.8 to 35 mSv (median 10.0 mSv, interquartile range 
[IQR] 6.4-12.5 mSv). Average doses for labs ranged from 2.2 to 24.4 mSv (median 10.4 mSv, IQR 8.0-12.6 mSv). The goal of ≤9mSv was achieved in 
36% of labs.
conclusions: Targeted MPI radiation dose levels are currently achieved in only a minority of laboratories. The variability in MPI radiation doses 
indicates numerous opportunities to reduce doses and improve quality of care.
